Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

FIXX - Q32 Bio Inc.


Close
0.96
0.960   100.000%

Share volume: 0
Last Updated: Mon 25 Mar 2024 05:01:38 PM CET
Pharmaceutical Preparation Manufacturing : 2.72%

PREVIOUS CLOSE
CHG
CHG%

N/A
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30
Fiscal Quarter Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023
Report Date 2022-05-16 2022-08-15 2022-11-10 2023-03-09 2023-05-11 2023-08-14 2023-11-14
Total revenue 802.000 K 802.000 K 802.000 K 802.000 K 802.000 K 354.000 K 0.000
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 802.000 K 802.000 K 802.000 K 802.000 K 802.000 K 354.000 K 0.000
    0.00% 0.00% 0.00% 0.00% -55.86% -100.00%  
Operating expenses 38.420 M 29.109 M 33.664 M 35.296 M 28.313 M 31.170 M 24.361 M
Selling general and admin 14.147 M 8.034 M 7.810 M 8.147 M 8.325 M 8.188 M 6.842 M
Research and development 24.273 M 21.075 M 25.854 M 27.149 M 19.988 M 22.982 M 17.519 M
Total expenses 38.420 M 29.109 M 33.664 M 35.296 M 28.313 M 31.170 M 24.361 M
    -24.23% 15.65% 4.85% -19.78% 10.09% -21.84%  
Operating income -37.618 M -28.307 M -32.862 M -34.494 M -27.511 M -30.816 M -24.361 M
Ebit -37.618 M -28.307 M -32.862 M -34.494 M -27.511 M -30.816 M -24.361 M
Pretax income 93.663 M -27.833 M -31.593 M -33.039 M -26.042 M -29.305 M -29.578 M
    -129.72% 13.51% 4.58% -21.18% 12.53% 0.93%  
Income tax 967.000 K -105.000 K -46.000 K -101.000 K 0.000 0.000 0.000
Net income basic 92.105 M -29.089 M -33.726 M -34.295 M -28.844 M -35.044 M -32.954 M
    -131.58% -15.94% -1.69% 15.89% -21.49% 5.96%  
Net income 92.105 M -29.089 M -33.726 M -34.295 M -28.844 M -35.044 M -32.954 M
    -131.58% -15.94% -1.69% 15.89% -21.49% 5.96%